Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and…
Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug…
Researchers at the Translational Genomics Research Institute (TGen) and physicians at Mayo Clinic’s Individualized Medicine Clinic have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies. Potential new…
The Ben & Catherine Ivy Foundation has awarded an $885,294 grant to Barrow Neurological Institute for brain cancer research. The Ivy Foundation is the largest privately funded brain cancer research foundation…
Investments by state governments in their own state universities can yield large returns and help create new industries. In Arizona, telemedicine is a good example of a success story. The…
The Alzheimer’s Prevention Initiative (API) trial in cognitively healthy individuals has reached a significant milestone with the first participants in Colombia receiving doses of an experimental anti-amyloid antibody, crenezumab designed…
The Ben & Catherine Ivy Foundation today announced a $3 million grant to the Translational Genomics Research Institute (TGen), Nemucore Medical Innovations Inc., and Barrow Neurological Institute at St. Joseph’s…
Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of…
In an effort to lower medical costs, identify patients at risk for injury, and speed patient recovery, scientists will attempt to identify a molecular signal that indicates severity of brain-injury…
Yves A. Lussier, MD, FAMCI, a professional engineer and physician-scientist who conducts research in translational bioinformatics and personal genomics, has joined the Arizona Health Sciences Center at the University of…
W. L. Gore & Associates announced that Brian Peterson, MD, from Saint Louis University, enrolled the first patient in the Gore EXCLUDER Iliac Branch Clinical Study, a prospective, multi-center, non-randomized,…
The absence of a protein called SMG1 could be a contributing factor in the development of Parkinson’s disease and other related neurological disorders, according to a study led by the…
